At Dana-Farber Cancer Institute and Brigham and Women’s Hospitals, we take pride in creating a number of pocket clinical resources for our clinicians.
The Dana-Farber Cancer Institute/ Brigham and Women’s Hospital Pain Management Tables and Guidelines (Pink Book) has been in use by DFCI/BWH clinicians since 1998. Widely used by the Harvard Interprofessional Palliative Care fellows and internal medicine house staff at Brigham and Women’s Hospital, the Pink Book contains useful opioid conversion tables, medication charts, and clinical pearls in the clinical management of pain.
The Pink Book is updated every other year by the BWH/DFCI Pain Management Tables and Guidelines Committee - consisting of DFCI palliative care pharmacists, physicians, and nurse practitioners.
In addition to the Pink Book, the DFCI palliative care service also created pocket references for Nausea and Vomiting (Green Book), and a Pediatric Pain and Symptom Management (Blue Book) guide in collaboration with the Pediatric Advanced Care Team at Boston Children’s Hospital.
Pinkbook.dfci.org was created as a central source for the most updated versions of the Pink Book, Green Book, and Blue Book. This site also contains useful links to additional references and other resources.
The website was created by Mark Zhang DO and Ben Kematick PharmD with support from the DFCI IS team. For questions regarding the pinkbook.dfci.org, please contact Mark Zhang DO (hzhang37@partners.org).
Disclaimer: Dana-Farber Cancer Institute/Brigham and Women's Hospital Pain Management Tables and Guidelines (Pink Book) Dana-Farber Cancer Institute/ Boston Children's Hospital Pediatric Pain and Symptom Management Guidelines (Blue Book) and, Dana-Farber Cancer Institute/ Brigham and Women's Hospital Guidelines for Assessment and Management of Nausea and Vomiting (Green Book) provide educational information for healthcare professionals at Dana-Farber and Brigham and Women's. This information is not medical advice. The Pink, Green, and Blue Books are not continually updated, and new safety information may emerge after a the most recent published date. Health care providers should always exercise their own independent clinical judgment and consult other relevant and up-to-date experts and resources. Official prescribing information should be consulted before any product is used or recommendation made.